speb/financial-data huggingface dataset:
Financial ratios for ML.PA — annual report dated 2022-12-31
Total revenue: 30414893617.02128
Gross profit: 8019148936.170213
Operating income: 3329787234.0425534
Net income: 2137234042.5531917
Capital expenditures: 2041489361.7021277
Operating cash flow: 2054255319.1489363
Depreciation & amortization: 2068085106.382979
Net tangible assets: 13698936170.212767
Owner earnings: 2163829787.234043
Return on net tangible assets (%): 15.795604566280968
Capex to operating income (%): 61.30990415335463
Buffett classification: The Good
Stock price: 23.425531914893618
P/E ratio: 7.8182729678048775
Shares outstanding: 713302016
Book value: 18208510638.297874
P/B ratio: 0.9176741290207993
Market cap (USD): 16709479140.765959
Debt to equity: 0.4288385136714185
Current ratio: 1.6678468687762782
Quick ratio: 0.9687984067271522
Effective tax rate (%): 24.359939759036145
Interest coverage ratio: 8.99425287356322
COGS to revenue (%): 73.63413781042323
R&D to revenue (%): 2.441413081497027
SG&A to revenue (%): 11.955229101084296
Free cash flow (dilution-adjusted): -223404255.31914896
Buyback yield (%): 0.7639949360039312
Retained earnings: 15048936170.212767
Inventory turnover: 3.3320671098448877
Receivables turnover: 6.7990487514863265
Capitalized R&D asset: 742553191.4893618
ROCI (R&D-adjusted, %): 13.31309091806759
FCF margin (%): -0.7345225603357818
Rule of 40 score: -0.7345225603357818
Financial ratios for ML.PA — annual report dated 2023-12-31
Total revenue: 31492222222.22222
Gross profit: 8831111111.11111
Operating income: 3828888888.888889
Net income: 2203333333.3333335
Capital expenditures: 2226666666.6666665
Operating cash flow: 5874444444.444445
Depreciation & amortization: 2231111111.111111
Net tangible assets: 14643333333.333332
Owner earnings: 2207777777.777778
Return on net tangible assets (%): 15.0770164655892
Capex to operating income (%): 58.15438189204875
Buffett classification: The Good
Stock price: 31.966666666666665
P/E ratio: 10.348814422753401
Shares outstanding: 713302016
Book value: 19953333333.333336
P/B ratio: 1.1427608308453054
Market cap (USD): 22801887778.13333
Debt to equity: 0.3464751085867022
Current ratio: 1.76510847107438
Quick ratio: 1.0617252066115699
Effective tax rate (%): 20.361445783132535
Interest coverage ratio: 8.904392764857882
COGS to revenue (%): 71.95780263204318
R&D to revenue (%): 2.667325265497654
SG&A to revenue (%): 12.51102565007233
Free cash flow (dilution-adjusted): 3347777777.7777777
Buyback yield (%): 0
Retained earnings: 16937777777.777777
Inventory turnover: 3.744262897007527
Receivables turnover: 7.361818181818181
Capitalized R&D asset: 1337510638.2978725
ROCI (R&D-adjusted, %): 13.007382012286103
Rosenberg metric: 1.0934734161095185
FCF margin (%): 10.63049077373602
Revenue growth (%): 3.542108740429823
Rule of 40 score: 14.172599514165842
Financial ratios for ML.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 14245833333.333334
Buffett classification: The Gruesome
Stock price: 30.447916666666668
Shares outstanding: 713302016
Book value: 19410416666.666668
P/B ratio: 1.1189126289406461
Market cap (USD): 21718560341.333336
Debt to equity: 0.3954599119888376
Current ratio: 1.7610792192881743
Quick ratio: 1.1067738231917335
Buyback yield (%): 0
Retained earnings: 16688541666.666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ML.PA — annual report dated 2024-12-31
Total revenue: 28326041666.666668
Gross profit: 8070833333.333334
Operating income: 3319791666.666667
Net income: 1968750000
Capital expenditures: 1983333333.3333335
Operating cash flow: 4516666666.666667
Depreciation & amortization: 2171875000
Net tangible assets: 14245833333.333334
Owner earnings: 2157291666.6666665
Return on net tangible assets (%): 15.143316759286341
Capex to operating income (%): 59.74270473799812
Buffett classification: The Good
Stock price: 30.447916666666668
P/E ratio: 11.031649697185186
Shares outstanding: 713302016
Book value: 19410416666.666668
P/B ratio: 1.1189126289406461
Market cap (USD): 21718560341.333336
Debt to equity: 0.3954599119888376
Current ratio: 1.7610792192881743
Quick ratio: 1.1067738231917335
Effective tax rate (%): 22.699386503067483
Interest coverage ratio: 10.803389830508475
COGS to revenue (%): 71.50737322104955
R&D to revenue (%): 2.8904497480969367
SG&A to revenue (%): 12.848894936196814
Free cash flow (dilution-adjusted): 2157291666.666667
Buyback yield (%): 2.407694886071643
Retained earnings: 16688541666.666668
Inventory turnover: 3.4120021056325673
Receivables turnover: 7.564116828929068
Capitalized R&D asset: 1626592553.1914895
ROCI (R&D-adjusted, %): 10.609962148878283
Rosenberg metric: -0.9050925925925913
FCF margin (%): 7.615930570367374
Revenue growth (%): -10.053849274953244
Rule of 40 score: -2.4379187045858695
Financial ratios for ML.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 32.380434782608695
Shares outstanding: 713302016
Market cap (USD): 23097029409.391304
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ML.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 15348235294.117647
Buffett classification: The Gruesome
Stock price: 35.49411764705883
Shares outstanding: 713302016
Book value: 20865882352.941174
P/B ratio: 1.2133695209021202
Market cap (USD): 25318025673.78824
Debt to equity: 0.42269959404600815
Current ratio: 1.8035888671875
Quick ratio: 1.118408203125
Buyback yield (%): 0
Retained earnings: 18848235294.11765
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSI.L — annual report dated 2022-04-30
Total revenue: 93155000
Gross profit: 25503750
Operating income: 6252500
Net income: 6165000
Capital expenditures: 3095000
Operating cash flow: -123750
Depreciation & amortization: 2466250
Net tangible assets: 44466250
Owner earnings: 5536250
Return on net tangible assets (%): 12.450453996008209
Capex to operating income (%): 49.50019992003199
Buffett classification: The Good
Stock price: 0.033874999999999995
P/E ratio: 0.09028851832927817
Shares outstanding: 16431844
Book value: 48218750
P/B ratio: 0.011543823004536616
Market cap (USD): 556628.7154999999
Debt to equity: 0.03917044718081659
Current ratio: 1.4929678188319429
Quick ratio: 1.006466030989273
Effective tax rate (%): 17.345399698340874
Interest coverage ratio: 22.63348416289593
COGS to revenue (%): 72.6222424990607
SG&A to revenue (%): 20.665825774247224
Free cash flow (dilution-adjusted): -3570000
Buyback yield (%): 0
Retained earnings: 30841250
Inventory turnover: 3.3148159490414653
Receivables turnover: 7.329989180682601
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.635538261997405
FCF margin (%): -3.832322473297193
Rule of 40 score: -3.832322473297193
Financial ratios for MSI.L — annual report dated 2023-04-30
Total revenue: 104945000
Gross profit: 29250000
Operating income: 6562500
Net income: 5143750
Capital expenditures: 2167500
Operating cash flow: -496250
Depreciation & amortization: 2853750
Net tangible assets: 48348750
Owner earnings: 5830000
Return on net tangible assets (%): 12.0582228082422
Capex to operating income (%): 33.02857142857143
Buffett classification: The Good
Stock price: 0.05962499999999999
P/E ratio: 0.19047362303766704
Shares outstanding: 16431844
Book value: 51343750
P/B ratio: 0.019082141419354836
Market cap (USD): 979748.6984999998
Debt to equity: 0.029409616555082167
Current ratio: 1.6261818181818182
Quick ratio: 0.8075371900826446
Effective tax rate (%): 18.9641591177629
Interest coverage ratio: 19.444444444444443
COGS to revenue (%): 72.12825765877365
SG&A to revenue (%): 21.618466815951212
Free cash flow (dilution-adjusted): -3067500
Buyback yield (%): 0
Retained earnings: 33335000
Inventory turnover: 2.445323857212082
Receivables turnover: 12.113114990621844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.700527892709372
FCF margin (%): -2.92295964552861
Revenue growth (%): 12.656325479040309
Rule of 40 score: 9.733365833511698
Financial ratios for MSI.L — annual report dated 2024-04-30
Total revenue: 136970000
Gross profit: 42335000
Operating income: 16930000
Net income: 14375000
Capital expenditures: 5730000
Operating cash flow: 45752500
Depreciation & amortization: 2756250
Net tangible assets: 62515000
Owner earnings: 11401250
Return on net tangible assets (%): 18.237622970487084
Capex to operating income (%): 33.845245126993504
Buffett classification: The Good
Stock price: 0.109125
P/E ratio: 0.1247391288
Shares outstanding: 16431844
Book value: 65575000
P/B ratio: 0.027344643179565382
Market cap (USD): 1793124.9765
Debt to equity: 0.015325962638200534
Current ratio: 1.520008702814428
Quick ratio: 1.1276050165508882
Effective tax rate (%): 26.807535641547865
Interest coverage ratio: 47.85865724381625
COGS to revenue (%): 69.09177192085858
SG&A to revenue (%): 18.547857195006205
Free cash flow (dilution-adjusted): 39371250
Buyback yield (%): 116.83513572429456
Retained earnings: 49576250
Inventory turnover: 2.9983366336633663
Receivables turnover: 7.451615096905814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.85392704820854
FCF margin (%): 28.74443308753742
Revenue growth (%): 30.515984563342702
Rule of 40 score: 59.26041765088012
Financial ratios for MSI.L — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 63185714.28571428
Buffett classification: The Gruesome
Stock price: 0.12532467532467534
Shares outstanding: 16431844
Book value: 66319480.51948051
P/B ratio: 0.031051442172874328
Market cap (USD): 2059315.5142857146
Debt to equity: 0.011690753142991424
Current ratio: 1.4281215713654691
Quick ratio: 0.8937034240036477
Buyback yield (%): 0
Retained earnings: 54024675.32467532
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSI.L — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 78429333.33333333
Buffett classification: The Gruesome
Stock price: 0.1312
Shares outstanding: 16431844
Book value: 81585333.33333333
P/B ratio: 0.026424577123339166
Market cap (USD): 2155857.9328
Debt to equity: 0.006765921979440749
Current ratio: 1.6030151553744267
Quick ratio: 1.1137608252674476
Buyback yield (%): 0
Retained earnings: 71089333.33333333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MSI.L — annual report dated 2025-04-30
Total revenue: 156670666.66666666
Gross profit: 53330666.666666664
Operating income: 25060000
Net income: 19374666.666666668
Capital expenditures: 4602666.666666667
Operating cash flow: -4332000
Depreciation & amortization: 3470666.6666666665
Net tangible assets: 78429333.33333333
Owner earnings: 18242666.666666668
Return on net tangible assets (%): 23.260004760123767
Capex to operating income (%): 18.366586858206972
Buffett classification: The Great
Stock price: 0.1312
P/E ratio: 0.11127200121120363
Shares outstanding: 16431844
Book value: 81585333.33333333
P/B ratio: 0.026424577123339166
Market cap (USD): 2155857.9328
Debt to equity: 0.006765921979440749
Current ratio: 1.6030151553744267
Quick ratio: 1.1137608252674476
Effective tax rate (%): 27.52618453865337
Interest coverage ratio: 722.8846153846155
COGS to revenue (%): 65.96001804209254
SG&A to revenue (%): 18.04464566862123
Free cash flow (dilution-adjusted): -9437333.333333334
Buyback yield (%): 277.2600755547027
Retained earnings: 71089333.33333333
Inventory turnover: 2.521882016073927
Receivables turnover: 4.576909593736611
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.351948179409167
FCF margin (%): -6.023675991251288
Revenue growth (%): 14.383198267260463
Rule of 40 score: 8.359522276009175
Financial ratios for MSI.L — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 81768421.05263157
Buffett classification: The Gruesome
Stock price: 0.21605263157894739
Shares outstanding: 16431844
Book value: 85228947.36842106
P/B ratio: 0.04165419434958471
Market cap (USD): 3550143.137894737
Debt to equity: 0.0035353691295890322
Current ratio: 1.979840532653816
Quick ratio: 1.4553861329168547
Buyback yield (%): 0
Retained earnings: 74543421.05263157
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MYSZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 101
Shares outstanding: 4818164
Market cap (USD): 486634564
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MYSZ — annual report dated 2022-12-31
Total revenue: 1266761.3636363635
Gross profit: 180113.63636363635
Operating income: -2154261.3636363638
Net income: -2360795.4545454546
Capital expenditures: 7670.454545454545
Operating cash flow: -2071022.7272727273
Depreciation & amortization: 54829.545454545456
Net tangible assets: 501136.36363636365
Owner earnings: -2313636.3636363638
Return on net tangible assets (%): -461.6780045351474
Buffett classification: The Gruesome
Stock price: 21.76
Shares outstanding: 4818164
Book value: 1288636.3636363638
P/B ratio: 81.35984021446208
Market cap (USD): 104843248.64
Debt to equity: 0.22001763668430335
Current ratio: 1.449629097870304
Quick ratio: 1.2110552763819094
Interest coverage ratio: -113.17910447761196
COGS to revenue (%): 85.78156537340212
R&D to revenue (%): 38.14756671899529
SG&A to revenue (%): 146.13141960080736
Free cash flow (dilution-adjusted): -2298579.5454545454
Buyback yield (%): 0
Retained earnings: -15199147.727272727
Inventory turnover: 3.8365095285857573
Receivables turnover: 1.8766835016835015
Capitalized R&D asset: 483238.63636363635
ROCI (R&D-adjusted, %): -88.96399503379777
FCF margin (%): -181.45324063691413
Rule of 40 score: -181.45324063691413
Financial ratios for MYSZ — annual report dated 2023-12-31
Total revenue: 1932596.6850828729
Gross profit: 754419.8895027624
Operating income: -1668784.5303867403
Net income: -1762430.9392265193
Capital expenditures: 1933.7016574585634
Operating cash flow: -1686740.3314917127
Depreciation & amortization: 90883.97790055249
Net tangible assets: 795580.1104972375
Owner earnings: -1673480.6629834254
Return on net tangible assets (%): -210.34722222222223
Buffett classification: The Gruesome
Stock price: 5.4
Shares outstanding: 4818164
Book value: 1308011.0497237567
P/B ratio: 19.891334714255546
Market cap (USD): 26018085.6
Debt to equity: 0.14656810982048576
Current ratio: 1.7088705518308407
Quick ratio: 0.9664775657555441
Interest coverage ratio: -107.875
COGS to revenue (%): 60.963407661520876
R&D to revenue (%): 13.922241280731845
SG&A to revenue (%): 111.46369353916523
Free cash flow (dilution-adjusted): -1813812.1546961325
Buyback yield (%): 0
Retained earnings: -16541712.70718232
Inventory turnover: 1.4814171587356721
Receivables turnover: 5.0078740157480315
Capitalized R&D asset: 592830.6598442993
ROCI (R&D-adjusted, %): -82.30797555884816
Rosenberg metric: 1.1884526813931355
FCF margin (%): -93.85363064608347
Revenue growth (%): 52.56201685336877
Rule of 40 score: -41.291613792714706
Financial ratios for MYSZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.68
Shares outstanding: 4818164
Market cap (USD): 8094515.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MYSZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.27
Shares outstanding: 4818164
Market cap (USD): 20573560.279999997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MYSZ — annual report dated 2024-12-31
Total revenue: 2262191.780821918
Gross profit: 910410.9589041097
Operating income: -983013.698630137
Net income: -1094520.5479452056
Capital expenditures: 1917.8082191780823
Operating cash flow: -847123.287671233
Depreciation & amortization: 86027.39726027398
Net tangible assets: 1650958.904109589
Owner earnings: -1010410.9589041097
Return on net tangible assets (%): -61.20146033853303
Buffett classification: The Gruesome
Stock price: 4.27
Shares outstanding: 4818164
Book value: 1892876.7123287674
P/B ratio: 10.868938344478215
Market cap (USD): 20573560.279999997
Debt to equity: 0.03994789405123751
Current ratio: 3.02803738317757
Quick ratio: 2.0947930574098796
Interest coverage ratio: -46
COGS to revenue (%): 59.75535908925759
R&D to revenue (%): 5.195591619232165
SG&A to revenue (%): 78.50308828872471
Free cash flow (dilution-adjusted): -955890.4109589041
Buyback yield (%): 0
Retained earnings: -17500273.97260274
Inventory turnover: 1.7646638054363373
Receivables turnover: 7.760338345864662
Capitalized R&D asset: 457273.7148073866
ROCI (R&D-adjusted, %): -48.296769598896994
Rosenberg metric: 0.5797614694382724
FCF margin (%): -42.25505631585321
Revenue growth (%): 17.05452039129994
Rule of 40 score: -25.20053592455327
Financial ratios for MYSZ — quarterly report dated 2025-03-31
Total revenue: 400813.0081300813
Gross profit: 113821.13821138212
Operating income: -287262.8726287263
Net income: -287262.8726287263
Capital expenditures: 0
Operating cash flow: -343631.43631436315
Depreciation & amortization: 11382.113821138211
Net tangible assets: 1404878.0487804879
Owner earnings: -275880.7588075881
Return on net tangible assets (%): -19.637345679012345
Buffett classification: The Gruesome
Stock price: 1.43
Shares outstanding: 4818164
Book value: 1633875.3387533873
P/B ratio: 4.216952393232709
Market cap (USD): 6889974.52
Debt to equity: 0.037983081771438054
Current ratio: 3.016621569385389
Quick ratio: 2.048705063780441
COGS to revenue (%): 71.60243407707911
R&D to revenue (%): 5.544286680189317
SG&A to revenue (%): 94.52332657200812
Free cash flow (dilution-adjusted): -349593.4959349593
Buyback yield (%): 0
Retained earnings: -17597831.978319783
Inventory turnover: 0.4229233226837061
Receivables turnover: 0.9214953271028037
Capitalized R&D asset: 22222.222222222223
ROCI (R&D-adjusted, %): -16.095634539438574
FCF margin (%): -87.2210953346856
Rule of 40 score: -87.2210953346856
Financial ratios for MYSZ — quarterly report dated 2025-06-30
Total revenue: 591740.412979351
Gross profit: 331563.42182890855
Operating income: -130383.4808259587
Net income: -132743.3628318584
Capital expenditures: 4719.76401179941
Operating cash flow: -306194.6902654867
Depreciation & amortization: 18289.08554572271
Net tangible assets: 1792625.3687315634
Owner earnings: -119174.0412979351
Return on net tangible assets (%): -6.648017113707421
Buffett classification: The Gruesome
Stock price: 1.22
Shares outstanding: 4818164
Book value: 2187020.6489675515
P/B ratio: 2.687747865012139
Market cap (USD): 5878160.08
Debt to equity: 0.02549231184246021
Current ratio: 3.8931050439611288
Quick ratio: 2.550670985654789
COGS to revenue (%): 43.96809571286141
R&D to revenue (%): 7.07876370887338
SG&A to revenue (%): 70.98703888334995
Free cash flow (dilution-adjusted): -324483.77581120946
Buyback yield (%): 0
Retained earnings: -19287905.60471976
Inventory turnover: 0.30403309203722856
Receivables turnover: 1.6308943089430894
Capitalized R&D asset: 56776.79449360865
ROCI (R&D-adjusted, %): -4.718384780900565
Rosenberg metric: 9.79840276278869
FCF margin (%): -54.835493519441684
Revenue growth (%): 47.635032041501375
Rule of 40 score: -7.200461477940308
Financial ratios for MYSZ — quarterly report dated 2025-09-30
Total revenue: 777039.2749244713
Gross profit: 304833.836858006
Operating income: -409667.6737160121
Net income: -403323.26283987914
Capital expenditures: 0
Operating cash flow: -151057.40181268883
Depreciation & amortization: 44108.76132930513
Net tangible assets: 1461631.419939577
Owner earnings: -359214.501510574
Return on net tangible assets (%): -24.576271186440675
Buffett classification: The Gruesome
Stock price: 1.19
Shares outstanding: 4818164
Book value: 2204229.6072507557
P/B ratio: 2.601187798739035
Market cap (USD): 5733615.16
Debt to equity: 0.12966008771929824
Current ratio: 2.7263726372637263
Quick ratio: 1.7227722772277225
COGS to revenue (%): 60.769828926905134
R&D to revenue (%): 5.093312597200622
SG&A to revenue (%): 86.85847589424573
Free cash flow (dilution-adjusted): -155891.23867069487
Buyback yield (%): 0
Retained earnings: -20157401.81268882
Inventory turnover: 0.4672645739910314
Receivables turnover: 2.0592473979183348
Capitalized R&D asset: 74975.26936342004
ROCI (R&D-adjusted, %): -15.630472941722573
Rosenberg metric: -0.6381217820518282
FCF margin (%): -20.06220839813375
Revenue growth (%): 31.314214456328898
Rule of 40 score: 11.25200605819515
Financial ratios for MYSZ — annual report dated 2025-12-31
Total revenue: 2944025.157232704
Gross profit: 943396.2264150943
Operating income: -1759748.427672956
Net income: -1840251.5723270439
Capital expenditures: 5031.446540880503
Operating cash flow: -1616981.1320754716
Depreciation & amortization: 107547.16981132075
Net tangible assets: 918553.4591194969
Owner earnings: -1737735.8490566036
Return on net tangible assets (%): -189.18178705922628
Buffett classification: The Gruesome
Stock price: 0.76
Shares outstanding: 4818164
Book value: 1621698.113207547
P/B ratio: 2.258006351599768
Market cap (USD): 3661804.64
Debt to equity: 0.20089199146790773
Current ratio: 1.8736383442265794
Quick ratio: 1.13919147906076
COGS to revenue (%): 67.95556505020295
R&D to revenue (%): 6.376842555009614
SG&A to revenue (%): 85.44114505447554
Free cash flow (dilution-adjusted): -1784591.1949685533
Buyback yield (%): 0
Retained earnings: -21927044.02515723
Inventory turnover: 2.096901779828609
Receivables turnover: 6.024453024453024
Capitalized R&D asset: 355273.849510702
ROCI (R&D-adjusted, %): -77.8560201997916
Rosenberg metric: 0.2806438844174687
FCF margin (%): -60.61738944669942
Revenue growth (%): 30.140387839401345
Rule of 40 score: -30.477001607298075
Financial ratios for MYSZ — quarterly report dated 2025-12-31
Total revenue: 1039308.1761006289
Gross profit: 140566.03773584904
Operating income: -861006.289308176
Net income: -945597.4842767295
Capital expenditures: 0
Operating cash flow: -734591.1949685534
Depreciation & amortization: 28930.81761006289
Net tangible assets: 918553.4591194969
Owner earnings: -916666.6666666666
Return on net tangible assets (%): -99.79459089352962
Buffett classification: The Gruesome
Stock price: 0.76
Shares outstanding: 4818164
Book value: 1621698.113207547
P/B ratio: 2.258006351599768
Market cap (USD): 3661804.64
Debt to equity: 0.20089199146790773
Current ratio: 1.8736383442265794
Quick ratio: 1.13919147906076
COGS to revenue (%): 86.4750378214826
R&D to revenue (%): 7.322239031770045
SG&A to revenue (%): 89.04689863842663
Free cash flow (dilution-adjusted): -870754.716981132
Buyback yield (%): 0
Retained earnings: -21927044.02515723
Inventory turnover: 0.941990771259064
Receivables turnover: 2.1267696267696268
Capitalized R&D asset: 116440.25409457451
ROCI (R&D-adjusted, %): -41.33018439248488
Rosenberg metric: -4.150583321330837
FCF margin (%): -83.7821482602118
Revenue growth (%): 33.75233526022869
Rule of 40 score: -50.02981299998311
Financial ratios for NFM.AX — annual report dated 2021-06-30
Operating income: -1255713.5338345864
Net income: -1221792.4812030075
Capital expenditures: 163372.18045112782
Net tangible assets: 14304780.451127818
Owner earnings: -1385164.6616541352
Return on net tangible assets (%): -9.683229088251585
Buffett classification: The Gruesome
Stock price: 0.03007518796992481
Shares outstanding: 1738296401
Book value: 14304780.451127818
P/B ratio: 3.6546937009017126
Market cap (USD): 52279591.00751879
Debt to equity: 0
Current ratio: 19.36966717730258
Quick ratio: 19.36966717730258
Free cash flow (dilution-adjusted): -2753304.5112781953
Buyback yield (%): 1.6293280008925246
Retained earnings: -14571015.789473683
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.778278968521906
Rule of 40 score: 0
Financial ratios for NFM.AX — annual report dated 2022-06-30
Operating income: -1126564.8275862068
Net income: -1140126.2068965517
Capital expenditures: 3525622.7586206896
Net tangible assets: 13007966.896551725
Owner earnings: -4665748.9655172415
Return on net tangible assets (%): -35.86839513524656
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 1738296401
Book value: 13111819.310344828
P/B ratio: 0.9143087437088875
Market cap (USD): 11988251.041379312
Debt to equity: 0
Current ratio: 46.533306209713444
Quick ratio: 46.533306209713444
Free cash flow (dilution-adjusted): -4495117.24137931
Buyback yield (%): 1.4322988867535482
Retained earnings: -14505264.827586208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.591979502778697
Rule of 40 score: 0
Financial ratios for NFM.AX — annual report dated 2023-06-30
Operating income: -4608162.251655629
Net income: -4597501.986754967
Capital expenditures: 1111333.774834437
Net tangible assets: 7895392.052980132
Owner earnings: -5708835.761589404
Return on net tangible assets (%): -72.30591873439131
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 1738296401
Book value: 7994217.880794702
P/B ratio: 1.440027888534337
Market cap (USD): 11511896.695364239
Debt to equity: 0
Current ratio: 23.190874666915995
Quick ratio: 23.190874666915995
Free cash flow (dilution-adjusted): -1839880.132450331
Buyback yield (%): 0
Retained earnings: -18526398.67549669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -57.64369098228197
Rule of 40 score: 0
Financial ratios for NMR — annual report dated 2022-03-31
Total revenue: 9373192919.193575
Net income: 1200893296.180954
Capital expenditures: 133961645.63186364
Operating cash flow: -7071234223.897722
Depreciation & amortization: 487821668.5789215
Net tangible assets: 23640370431.076874
Owner earnings: 1554753319.128012
Return on net tangible assets (%): 6.5766876355041495
Buffett classification: The Gruesome
Stock price: 3.89
P/E ratio: 9.468247571286868
Shares outstanding: 2922970446
Book value: 24363243730.53601
P/B ratio: 0.4667011979479894
Market cap (USD): 11370355034.94
Debt to equity: 3.6675383468060234
Effective tax rate (%): 35.34063179818465
COGS to revenue (%): 0
SG&A to revenue (%): 46.29694233800844
Free cash flow (dilution-adjusted): -8212620881.822653
Buyback yield (%): 2.857841545367099
Retained earnings: 13169865595.803967
Receivables turnover: 0.667458984009118
Capitalized R&D asset: 0
FCF margin (%): -87.61817827312177
Rule of 40 score: -87.61817827312177
Financial ratios for NMR — annual report dated 2023-03-31
Total revenue: 8595878378.37838
Net income: 696591591.5915916
Capital expenditures: 807184684.6846848
Operating cash flow: -5216366366.366366
Depreciation & amortization: 461141141.1411412
Net tangible assets: 23366163663.663666
Owner earnings: 350548048.048048
Return on net tangible assets (%): 1.5002379213545418
Buffett classification: The Gruesome
Stock price: 3.5
P/E ratio: 14.686362403004763
Shares outstanding: 2922970446
Book value: 24205270270.270264
P/B ratio: 0.4226516145769015
Market cap (USD): 10230396561
Debt to equity: 3.7020556166570837
Effective tax rate (%): 38.66759436423726
COGS to revenue (%): 0
SG&A to revenue (%): 52.9085016127046
Free cash flow (dilution-adjusted): -6765773273.273273
Buyback yield (%): 1.8146475998140503
Retained earnings: 12364902402.402403
Receivables turnover: 0.7653022552591634
Capitalized R&D asset: 0
FCF margin (%): -78.70950443286335
Revenue growth (%): -8.292953612674298
Rule of 40 score: -87.00245804553765
Financial ratios for NMR — annual report dated 2024-03-31
Total revenue: 9099425515.055468
Net income: 1170232435.2879028
Capital expenditures: 223388800.84521922
Operating cash flow: 875858425.7791865
Depreciation & amortization: 405044902.2715267
Net tangible assets: 21868740095.087162
Owner earnings: 1351888536.7142105
Return on net tangible assets (%): 6.181830918635838
Buffett classification: The Gruesome
Stock price: 6.01
P/E ratio: 15.011592441580307
Shares outstanding: 2922970446
Book value: 22771480454.305298
P/B ratio: 0.7714497270263637
Market cap (USD): 17567052380.46
Debt to equity: 4.085776101177529
Effective tax rate (%): 35.28574036881505
COGS to revenue (%): 0
SG&A to revenue (%): 48.87624753540776
Free cash flow (dilution-adjusted): -321718172.2134179
Buyback yield (%): 2.2940176584488055
Retained earnings: 11263371632.329636
Receivables turnover: 0.8185390268415713
Capitalized R&D asset: 0
FCF margin (%): -3.5355877322268165
Revenue growth (%): 5.858006762213897
Rule of 40 score: 2.3224190299870804
Financial ratios for NMR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.03
Shares outstanding: 2922970446
Market cap (USD): 14702541343.380001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NMR — quarterly report dated 2024-12-31
Total revenue: 2919523536.530989
Net income: 663367093.4454423
Capital expenditures: 0
Net tangible assets: 22739856041.7861
Owner earnings: 663367093.4454423
Return on net tangible assets (%): 2.917200057143978
Buffett classification: The Gruesome
Stock price: 5.57
P/E ratio: 6.135722417153257
Shares outstanding: 2922970446
Book value: 23409809542.009033
P/B ratio: 0.6954753457094025
Market cap (USD): 16280945384.220001
Debt to equity: 4.192783827187571
Effective tax rate (%): 24.687045755320767
COGS to revenue (%): 0
SG&A to revenue (%): 41.64804859317182
Buyback yield (%): 0
Retained earnings: 12076890247.786482
Receivables turnover: 0.2931646761433996
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NMR — quarterly report dated 2025-03-31
Total revenue: 2374167891.993049
Net income: 494412511.6962973
Capital expenditures: 0
Net tangible assets: 22707752974.20131
Owner earnings: 494412511.6962973
Return on net tangible assets (%): 2.1772850543953353
Buffett classification: The Gruesome
Stock price: 6.15
P/E ratio: 9.089711434094067
Shares outstanding: 2922970446
Book value: 23933959363.721436
P/B ratio: 0.7510779127563838
Market cap (USD): 17976268242.9
Debt to equity: 4.205117622205422
Effective tax rate (%): 24.31862825339663
COGS to revenue (%): 0
SG&A to revenue (%): 48.510653870948666
Buyback yield (%): 0
Retained earnings: 12480811388.851757
Receivables turnover: 0.21647320220651864
Capitalized R&D asset: 0
Revenue growth (%): -18.679611166482932
Rule of 40 score: -18.679611166482932
Financial ratios for NMR — annual report dated 2025-03-31
Total revenue: 11110640288.731453
Net income: 2320912979.5481887
Capital expenditures: 393617163.48081803
Operating cash flow: -4535563427.349285
Depreciation & amortization: 412063895.2011763
Net tangible assets: 22707752974.20131
Owner earnings: 2339359711.268547
Return on net tangible assets (%): 10.302030825887247
Buffett classification: The Gruesome
Stock price: 6.15
P/E ratio: 7.745343492542075
Shares outstanding: 2922970446
Book value: 23933959363.721436
P/B ratio: 0.7510779127563838
Market cap (USD): 17976268242.9
Debt to equity: 4.205117622205422
Effective tax rate (%): 26.423413650193663
COGS to revenue (%): 0
SG&A to revenue (%): 44.05687288179435
Free cash flow (dilution-adjusted): -6063093169.362385
Buyback yield (%): 2.1938502740209396
Retained earnings: 12480811388.851757
Receivables turnover: 1.0130521476505159
Capitalized R&D asset: 0
FCF margin (%): -54.57015088060809
Revenue growth (%): 22.102656594620473
Rule of 40 score: -32.46749428598761
Financial ratios for NMR — quarterly report dated 2025-06-30
Total revenue: 3311216440.6310544
Net income: 743661776.9166896
Capital expenditures: 0
Net tangible assets: 24052131192.914474
Owner earnings: 743661776.9166896
Return on net tangible assets (%): 3.09187477380701
Buffett classification: The Gruesome
Stock price: 6.58
P/E ratio: 10.115034686927302
Shares outstanding: 2922970446
Book value: 24833593966.233032
P/B ratio: 0.7744809535354356
Market cap (USD): 19233145534.68
Debt to equity: 4.344547194988176
Effective tax rate (%): 32.94693103405248
COGS to revenue (%): 0
SG&A to revenue (%): 38.93324863072239
Buyback yield (%): 0
Retained earnings: 13583649321.893162
Receivables turnover: 0.3528849153178558
Capitalized R&D asset: 0
Revenue growth (%): 39.46850396714693
Rule of 40 score: 39.46850396714693
Financial ratios for NMR — quarterly report dated 2025-09-30
Total revenue: 3151218034.993271
Net income: 644636608.3445492
Capital expenditures: 0
Net tangible assets: 22942920592.19381
Owner earnings: 644636608.3445492
Return on net tangible assets (%): 2.809740833797258
Buffett classification: The Gruesome
Stock price: 7.27
P/E ratio: 8.346168193793888
Shares outstanding: 2922970446
Book value: 24284380888.29071
P/B ratio: 0.875047844133683
Market cap (USD): 21249995142.42
Debt to equity: 4.478637078205506
Effective tax rate (%): 29.89644699769476
COGS to revenue (%): 0
SG&A to revenue (%): 41.65942370977489
Buyback yield (%): 0
Retained earnings: 13296796769.851952
Receivables turnover: 0.2679443112809653
Capitalized R&D asset: 0
Revenue growth (%): -4.832012902403048
Rule of 40 score: -4.832012902403048
Financial ratios for NMR — quarterly report dated 2025-12-31
Total revenue: 3182392430.151525
Net income: 604475417.1728151
Capital expenditures: 0
Net tangible assets: 23347720733.96842
Owner earnings: 604475417.1728151
Return on net tangible assets (%): 2.5890125381419713
Buffett classification: The Gruesome
Stock price: 8.39
P/E ratio: 9.860026127763074
Shares outstanding: 2922970446
Book value: 24388415062.975525
P/B ratio: 1.005548002140159
Market cap (USD): 24523722041.940002
Debt to equity: 4.35104960111068
Effective tax rate (%): 30.080386922149664
COGS to revenue (%): 0
SG&A to revenue (%): 44.346650380305285
Buyback yield (%): 0
Retained earnings: 13217562815.676746
Receivables turnover: 0.3664223399564349
Capitalized R&D asset: 0
Revenue growth (%): 0.989280805455936
Rule of 40 score: 0.989280805455936
Financial ratios for NTRP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.8
Shares outstanding: 14823153
Market cap (USD): 545492030.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTRP — annual report dated 2022-12-31
Total revenue: 630428
Gross profit: 280498
Operating income: -8672376
Net income: -8692424
Capital expenditures: 164622
Operating cash flow: -8212154
Depreciation & amortization: 116167
Net tangible assets: 3949425
Owner earnings: -8740879
Return on net tangible assets (%): -221.32029346044044
Buffett classification: The Gruesome
Stock price: 8
Shares outstanding: 14823153
Book value: 5074710
P/B ratio: 23.36788190852285
Market cap (USD): 118585224
Debt to equity: 0
Current ratio: 6.792329282674134
Quick ratio: 5.280971967488772
Interest coverage ratio: -1180.7183117767188
COGS to revenue (%): 55.50673510694322
R&D to revenue (%): 103.6111974721935
SG&A to revenue (%): 1059.854257742359
Free cash flow (dilution-adjusted): -9508499
Buyback yield (%): 0
Retained earnings: -49342484
Inventory turnover: 0.36798209777031854
Receivables turnover: 1.6964318389752973
Capitalized R&D asset: 653194
ROCI (R&D-adjusted, %): -143.8032713769877
FCF margin (%): -1508.260895772396
Rule of 40 score: -1508.260895772396
Financial ratios for NTRP — annual report dated 2023-02-28
Total revenue: 382832
Gross profit: 27911
Operating income: -4951855
Net income: -5033496
Capital expenditures: 2928
Operating cash flow: -3792600
Depreciation & amortization: 719406
Net tangible assets: -2123560
Owner earnings: -4317018
Buffett classification: The Gruesome
Stock price: 11.9
Shares outstanding: 14823153
Book value: 484110
P/B ratio: 364.37074363264543
Market cap (USD): 176395520.70000002
Debt to equity: 9.35410753754312
Current ratio: 0.4905572519925479
Quick ratio: 0.4905572519925479
Interest coverage ratio: -68.89920830376647
COGS to revenue (%): 92.70933464287207
R&D to revenue (%): 144.03654866886782
SG&A to revenue (%): 900.3596878003929
Free cash flow (dilution-adjusted): -6149622
Buyback yield (%): 0
Retained earnings: -16811863
Receivables turnover: 0.19795771050122343
Capitalized R&D asset: 989057.98
ROCI (R&D-adjusted, %): -205.41070487283991
Rosenberg metric: -0.3866952237773158
FCF margin (%): -1606.350043883479
Revenue growth (%): -39.274270812844605
Rule of 40 score: -1645.6243146963236
Financial ratios for NTRP — annual report dated 2024-02-29
Total revenue: 458752
Gross profit: 61220
Operating income: -7247022
Net income: -7332151
Capital expenditures: 9253
Operating cash flow: -5731409
Depreciation & amortization: 1468762
Net tangible assets: -213196
Owner earnings: -5872642
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 14823153
Book value: 3128029
P/B ratio: 14.169059004887744
Market cap (USD): 44321227.470000006
Debt to equity: 0.2647919824272729
Current ratio: 0.8663794048693068
Quick ratio: 0.8663794048693068
Interest coverage ratio: -149.0543397778692
COGS to revenue (%): 86.65509905133929
R&D to revenue (%): 67.8863525390625
SG&A to revenue (%): 823.7267630440849
Free cash flow (dilution-adjusted): -6873349
Buyback yield (%): 0
Retained earnings: -24151139
Receivables turnover: 0.4436321297537333
Capitalized R&D asset: 896434.0800000001
ROCI (R&D-adjusted, %): -184.89272197108423
Rosenberg metric: 0.06040608032381968
FCF margin (%): -1498.2711791992188
Revenue growth (%): 19.83115309065073
Rule of 40 score: -1478.440026108568
Financial ratios for NTRP — quarterly report dated 2024-08-31
Capital expenditures: 220162
Buffett classification: The Gruesome
Stock price: 2.59
Shares outstanding: 14823153
Market cap (USD): 38391966.269999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTRP — quarterly report dated 2024-11-30
Total revenue: 74635
Gross profit: -2116
Operating income: -1773527
Net income: -2009263
Capital expenditures: 79183
Operating cash flow: -1182805
Depreciation & amortization: 148803
Net tangible assets: -4825229
Owner earnings: -1939643
Buffett classification: The Gruesome
Stock price: 3.82
Shares outstanding: 14823153
Book value: -1415346
Market cap (USD): 56624444.46
Debt to equity: -2.6799976825454697
Current ratio: 0.2384247533310802
Quick ratio: 0.2384247533310802
COGS to revenue (%): 102.83513097072418
SG&A to revenue (%): 1710.4213840691366
Free cash flow (dilution-adjusted): -1268216
Buyback yield (%): 0
Retained earnings: -29705833
Receivables turnover: 0.07347750880381353
Capitalized R&D asset: 0
FCF margin (%): -1699.2242245595228
Rule of 40 score: -1699.2242245595228
Financial ratios for NTRP — quarterly report dated 2025-02-28
Total revenue: 83497
Gross profit: -8836
Operating income: -3218208
Net income: -4597453
Capital expenditures: 66000
Operating cash flow: -1944801
Depreciation & amortization: 181433
Net tangible assets: 4069894
Owner earnings: -4482020
Return on net tangible assets (%): -110.12620967523969
Buffett classification: The Gruesome
Stock price: 3.98
Shares outstanding: 14823153
Book value: 7365067
P/B ratio: 8.010266429348164
Market cap (USD): 58996148.94
Debt to equity: 0.07705700436941035
Current ratio: 0.9589368072479878
Quick ratio: 0.9589368072479878
COGS to revenue (%): 110.58241613471142
SG&A to revenue (%): 1933.64791549397
Free cash flow (dilution-adjusted): -2042212
Buyback yield (%): 0
Retained earnings: -34349823
Receivables turnover: 0.1104250259871823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.69556991131242
FCF margin (%): -2445.850749128711
Revenue growth (%): 11.873785757352447
Rule of 40 score: -2433.9769633713586
Financial ratios for NTRP — annual report dated 2025-02-28
Total revenue: 501423
Gross profit: 3302
Operating income: -8413429
Net income: -10120084
Capital expenditures: 0
Operating cash flow: -5080154
Depreciation & amortization: 713236
Net tangible assets: 4069894
Owner earnings: -9406848
Return on net tangible assets (%): -231.13250615372291
Buffett classification: The Gruesome
Stock price: 3.98
Shares outstanding: 14823153
Book value: 7365067
P/B ratio: 8.010266429348164
Market cap (USD): 58996148.94
Debt to equity: 0.07705700436941035
Current ratio: 0.9589368072479878
Quick ratio: 0.9589368072479878
COGS to revenue (%): 99.34147416452775
R&D to revenue (%): 168.18055813155758
SG&A to revenue (%): 1062.8800433964934
Free cash flow (dilution-adjusted): -5682779
Buyback yield (%): 0
Retained earnings: -34349823
Receivables turnover: 0.6631333797091022
Capitalized R&D asset: 1233922.04
ROCI (R&D-adjusted, %): -94.64888987306661
Rosenberg metric: -0.18597437626432906
FCF margin (%): -1133.330341847103
Revenue growth (%): 9.301539829799108
Rule of 40 score: -1124.0288020173039
Financial ratios for NTRP — quarterly report dated 2025-05-31
Total revenue: 138827
Gross profit: 38906
Operating income: -4639737
Net income: -4457232
Capital expenditures: 81503
Operating cash flow: -1042658
Depreciation & amortization: 206650
Net tangible assets: 454009
Owner earnings: -4332085
Return on net tangible assets (%): -954.1848289351092
Buffett classification: The Gruesome
Stock price: 2.05
Shares outstanding: 14823153
Book value: 6669918
P/B ratio: 4.555897636222814
Market cap (USD): 30387463.65
Debt to equity: 0.35172756246778447
Current ratio: 0.5767017066140833
Quick ratio: 0.5767017066140833
Interest coverage ratio: -16.790383341837565
COGS to revenue (%): 71.9751921456201
SG&A to revenue (%): 1516.5191209202821
Free cash flow (dilution-adjusted): -3211030
Buyback yield (%): 0
Retained earnings: -38871518
Receivables turnover: 1.2606768917826754
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.20347051876079
FCF margin (%): -2312.9722604392514
Revenue growth (%): 66.26585386301305
Rule of 40 score: -2246.7064065762384
Financial ratios for NTRP — quarterly report dated 2025-08-31
Total revenue: 757648
Gross profit: 165575
Operating income: -3202877
Net income: -2898155
Capital expenditures: 27497
Operating cash flow: 572375
Depreciation & amortization: 216625
Net tangible assets: -1613151
Owner earnings: -2709027
Buffett classification: The Gruesome
Stock price: 3.83
Shares outstanding: 14823153
Book value: 5591536
P/B ratio: 10.153323879163079
Market cap (USD): 56772675.99
Debt to equity: 0.6261649750623085
Current ratio: 0.7044936494953393
Quick ratio: 0.7044936494953393
COGS to revenue (%): 78.14631596730935
SG&A to revenue (%): 307.6349439317467
Free cash flow (dilution-adjusted): 124713
Buyback yield (%): 0
Retained earnings: -41952936
Receivables turnover: 2.8385259782103733
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.95246773273999
FCF margin (%): 16.460546322302704
Revenue growth (%): 445.7497460868563
Rule of 40 score: 462.210292409159
Financial ratios for NTRP — quarterly report dated 2025-11-30
Total revenue: 1200130
Gross profit: 217478
Operating income: -3084782
Net income: -3275566
Capital expenditures: 0
Operating cash flow: -1980577
Depreciation & amortization: 272628
Net tangible assets: -1044238
Owner earnings: -3002938
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 14823153
Book value: 5888180
P/B ratio: 9.364885102017942
Market cap (USD): 55142129.160000004
Debt to equity: 0.6966008172304515
Current ratio: 0.8515016149004384
Quick ratio: 0.8515016149004384
COGS to revenue (%): 81.87879646371643
SG&A to revenue (%): 214.84514177630757
Free cash flow (dilution-adjusted): -1980577
Buyback yield (%): 0
Retained earnings: -45239191
Receivables turnover: 3.222361842776516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.90947345602056
FCF margin (%): -165.03020506111838
Revenue growth (%): 58.402054780056176
Rule of 40 score: -106.6281502810622
Financial ratios for OCS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.69
Shares outstanding: 60388073
Market cap (USD): 585160427.37
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -35191304.347826086
Net income: -42063043.47826087
Capital expenditures: 70652.17391304347
Operating cash flow: -27254347.826086957
Depreciation & amortization: 325000
Net tangible assets: -119779347.82608695
Owner earnings: -41808695.652173914
Buffett classification: The Gruesome
Stock price: 10.1
Shares outstanding: 60388073
Book value: -106511956.52173914
Market cap (USD): 609919537.3
Debt to equity: -1.2495943505015765
Current ratio: 1.9681364392678868
Quick ratio: 1.9681364392678868
Interest coverage ratio: -5.025768394908414
Free cash flow (dilution-adjusted): -31984782.608695652
Buyback yield (%): 0
Retained earnings: -120628260.86956522
Receivables turnover: 0
Capitalized R&D asset: 24156521.739130434
ROCI (R&D-adjusted, %): -37.15301286391334
Rule of 40 score: 0
Financial ratios for OCS — annual report dated 2023-12-31
Total revenue: 0
Operating income: -54584523.80952381
Net income: -105716666.66666667
Capital expenditures: 57142.857142857145
Operating cash flow: -65520238.0952381
Depreciation & amortization: 341666.6666666667
Net tangible assets: 97050000
Owner earnings: -105432142.85714285
Return on net tangible assets (%): -108.63693236181643
Buffett classification: The Gruesome
Stock price: 11.23
Shares outstanding: 60388073
Book value: 111580952.38095239
P/B ratio: 6.077722454587743
Market cap (USD): 678158059.7900001
Debt to equity: 0.006454848071013998
Current ratio: 5.292068315171836
Quick ratio: 5.292068315171836
Interest coverage ratio: -34.86768060836502
Free cash flow (dilution-adjusted): -69872619.04761904
Buyback yield (%): 0
Retained earnings: -237833333.33333334
Receivables turnover: 0
Capitalized R&D asset: 51002726.70807453
ROCI (R&D-adjusted, %): -23.979057139344164
Rule of 40 score: 0
Financial ratios for OCS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.26
Shares outstanding: 60388073
Market cap (USD): 740357774.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17
Shares outstanding: 60388073
Market cap (USD): 1026597241
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OCS — annual report dated 2024-12-31
Total revenue: 0
Operating income: -81337777.77777778
Net income: -95307777.77777778
Capital expenditures: 255555.55555555556
Operating cash flow: -54354444.44444444
Depreciation & amortization: 451111.1111111111
Net tangible assets: 66767777.777777776
Owner earnings: -95112222.22222222
Return on net tangible assets (%): -142.45228070759347
Buffett classification: The Gruesome
Stock price: 17
Shares outstanding: 60388073
Book value: 81536666.66666666
P/B ratio: 12.590620673725523
Market cap (USD): 1026597241
Debt to equity: 0.016080018532902716
Current ratio: 2.371357522323952
Quick ratio: 2.371357522323952
Interest coverage ratio: -114.56025039123631
Free cash flow (dilution-adjusted): -65478888.88888889
Buyback yield (%): 0
Retained earnings: -317285555.5555555
Receivables turnover: 0
Capitalized R&D asset: 89169616.45962733
ROCI (R&D-adjusted, %): -35.92382070122752
Rule of 40 score: 0
Financial ratios for OCS — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -22697727.272727273
Net income: -37742045.45454545
Capital expenditures: 14772.727272727272
Operating cash flow: -21548863.636363637
Depreciation & amortization: 139772.72727272726
Net tangible assets: 169697727.27272728
Owner earnings: -37617045.45454545
Return on net tangible assets (%): -22.167088539783304
Buffett classification: The Gruesome
Stock price: 19.03
Shares outstanding: 60388073
Book value: 184802272.72727272
P/B ratio: 6.218457231237318
Market cap (USD): 1149185029.19
Debt to equity: 0.006782433313246344
Current ratio: 4.785283382338031
Quick ratio: 4.785283382338031
Interest coverage ratio: -80.8663967611336
Free cash flow (dilution-adjusted): -25787500
Buyback yield (%): 0
Retained earnings: -362238636.3636364
Receivables turnover: 0
Capitalized R&D asset: 16785227.272727273
ROCI (R&D-adjusted, %): -5.6419113413932065
Rule of 40 score: 0
Financial ratios for OCS — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -25960000
Net income: -31718750
Capital expenditures: 157500
Operating cash flow: -21552500
Depreciation & amortization: 141250
Net tangible assets: 162255000
Owner earnings: -31735000
Return on net tangible assets (%): -19.55871929986749
Buffett classification: The Gruesome
Stock price: 19.41
Shares outstanding: 60388073
Book value: 178870000
P/B ratio: 6.5529853912338565
Market cap (USD): 1172132496.93
Debt to equity: 0.007197965002515794
Current ratio: 4.547693318010179
Quick ratio: 4.547693318010179
Interest coverage ratio: -113.48633879781421
Free cash flow (dilution-adjusted): -27385000
Buyback yield (%): 0
Retained earnings: -430182500
Receivables turnover: 0
Capitalized R&D asset: 29882352.272727273
ROCI (R&D-adjusted, %): -9.05707622546004
Rule of 40 score: 0